Egyptian companies of blood products suffer a shortage in medicines needed for blood transfusion and production, National Blood Transfusion Center chairperson Hala Adly told Youm7 on Tuesday.
She added that all Egyptian companies need a total f $90 million annually to buy the required medicines; however, there is a shortage due to dollar crisis Egypt witnesses.
She continued that the Central Bank of Egypt has been notified about the required amount of money to import the medicine. The CBE struggles to provide hard currency to other banks, so the importers find no dollar liquidity required to buy their raw materials.
